The activation of inflammatory signaling pathways such as NF-κB and NLRP3, and the release of ROS may be the main mechanism of TMAO's involvement in cardiovascular and cerebrovascular diseases (Liu et al., 2022, Praveenraj et al., 2022). Here, NFKB1 is linked to cerebrovascular disorder.